Not finding it? Sign in to also search OpenAlex live.
-
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment2022 Transplantation and Cellular Therapy article Medicine Multiple Myeloma Research and Treatments Open access
Marta Reinoso‐Segura, Teresa Caballero‐Velázquez, Pilar Herrera, Francesca F. Patriarca, Renato Fanin, Benedetto Bruno, +8 more
7citations -
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance2020 Pediatric Rheumatology article Medicine Autoimmune and Inflammatory Disorders Research Open access
Rosanne M. Smits, Dieuwke Swaantje Veldhuijzen, Henriët van Middendorp, Petra C. E. Hissink Muller, Wineke Armbrust, G. Elizabeth Legger, +2 more
5citations -
Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle Randomized Clinical Trial
Meriem Manaï, Henriët van Middendorp, Joy Ardjuna van der Pol, Cornelia F Allaart, Elise Dusseldorp, Dieuwke Swaantje Veldhuijzen, +2 more
0citations -
590 Pre-conditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy2020 Regular and Young Investigator Award Abstracts conference-paper Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access
Christianne Groeneveldt, Priscilla Kinderman, Diana J.M. van den Wollenberg, Ruben L van den Oever, Jim Middelburg, Dana AM Mustafa, +4 more
3citations -
Abstract CT194: Low-dose Interferon-alpha pre-conditioning and adoptive cell therapy in metastatic melanoma patients refractory to standard (immune) therapies - a phase 1/2 study
Monique K. van der Kooij, Els M.E. Verdegaal, Marten Visser, Carolien E. van der Minne, Linda de Bruin, Pauline Meij, +8 more
0citations -
Treosulfan Compared to Busulfan in Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis: A Registry-Based Study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Jakob Robert Passweg, Linda Köster, Victoria T. Potter, Keith M. O. Wilson, +19 more
3citations -
Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party
Josu de la Fuente, Jacques‐Emmanuel Galimard, Arnaud Dalissier, Mohsen Al Zahrani, Ali Debsan Alahmari, Ashrafsadat Mousavi, +14 more
1citations -
Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT
Firoozeh Sahebi, Dirk‐Jan Eikema, Linda Köster, Nicolaus Martin Kröger, Ellen Meijer, Goda Choi, +19 more
1citations -
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Outcomes in Leukocyte Adhesion Deficiency Type -I2024 Blood conference-abstract Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
Claire Booth, Luuk A. Gras, Hawazen Saleh Alsaedi, Amir Ali Hamidieh, Mor Sény Gueye, Mary Anne Slatter, +18 more
0citations -
Late Endocrine Effects After HSCT in Children With Nonmalignant Diseases; A Single Center Cohort Analysis2021 Journal of the Endocrine Society article Medicine Hematopoietic Stem Cell Transplantation Open access
Liselotte C. de Kloet, Joëll E. Bense, Eileen van der Stoep-Yap, Marloes Louwerens, Erik G. J. von Asmuth, Adriaan C Lankester, +2 more
0citations -
Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle2023 Frontiers in Immunology article Medicine CAR-T cell therapy research Open access cited by 6 patents
Benno Lickefett, Lulu Chu, Valentín Ortiz‐Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, +14 more
177citations -
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study2021 CPT Pharmacometrics & Systems Pharmacology article Medicine Pharmaceutical studies and practices Open access
Khalil Ben Hassine, Tiago Nava, Yves Théorêt, Christa Ellen Nath, Youssef Daali, Nastya Kassir, +7 more
23citations -
Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT
Josu de la Fuente, Dirk‐Jan Eikema, Paul V. Bosman, Robert Wynn, Miguel Ángel Díaz, Peter John Shaw, +24 more
1citations -
Encouraging Outcome of AML with t(8;16) Following Allogeneic Stem Cell Transplantation in First Remission - a Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
Ann‐Kristin Schmälter, Myriam Labopin, Jurjen Versluis, Maria Pilar Gallego Hernanz, Matthias Eder, Peter A. von dem Borne, +12 more
1citations -
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study2021 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
M. Y. Eileen C. van der Stoep, Alice Bertaina, Dirk Jan A. R. Moes, Mattia Algeri, Robbert G. M. Bredius, Frans J. W. Smiers, +7 more
27citations